Cargando…
CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma
CIP2A is a well-known oncoprotein whose expression is elevated in multiple human solid tumor types. However, its role in renal cell carcinoma (RCC) development is poorly understood. Thus, in our present study, we used the renal cancer cell lines 786-O, A498 and CAKI-1 and the renal epithelial cell l...
Autores principales: | Zhang, Yongzhen, Fang, Liang, Zang, Yuanwei, Ren, Juchao, Xu, Zhonghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218763/ https://www.ncbi.nlm.nih.gov/pubmed/30410608 http://dx.doi.org/10.7150/jca.25005 |
Ejemplares similares
-
Eukaryotic Translation Initiation Factor 3b is both a Promising Prognostic Biomarker and a Potential Therapeutic Target for Patients with Clear Cell Renal Cell Carcinoma
por: Zang, Yuanwei, et al.
Publicado: (2017) -
Cytoplasmic Expression of Pontin in Renal Cell Carcinoma Correlates with Tumor Invasion, Metastasis and Patients’ Survival
por: Zhang, Xiang, et al.
Publicado: (2015) -
Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia
por: Yang, Feilong, et al.
Publicado: (2017) -
Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer
por: Zhang, Yongzhen, et al.
Publicado: (2018) -
Erythrocytosis caused by giant chromophobe renal cell carcinoma: a case report indicating a 9-year misdiagnosis of polycythemia vera
por: Guo, Renbo, et al.
Publicado: (2017)